Litigation Details for Ariad Pharmaceuticals, Inc. v. Matal (E.D. Va. 2017)
✉ Email this page to a colleague
Ariad Pharmaceuticals, Inc. v. Matal (E.D. Va. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-06-26 |
| Court | District Court, E.D. Virginia | Date Terminated | 2018-01-09 |
| Cause | 35:154 AIA Appeal of Patent Term Adjustment Determination | Assigned To | Thomas Selby Ellis III |
| Jury Demand | Referred To | Ivan D. Davis | |
| Patents | 8,114,874 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Ariad Pharmaceuticals, Inc. v. Matal
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Ariad Pharmaceuticals, Inc. v. Matal (E.D. Va. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-01-04 | 29 | for United States Patent No. 8,114,874 (the “’874 Patent”), owned by plaintiff ARIAD Pharmaceuticals (… the owner of the United States Patent No. 8,114,874 (the “’874 Patent”), relating to an invention designed…process, a patent issues, the patent term will last for twenty years from the date the initial patent application…that a patent holder is entitled to an adjusted patent term “if the issue of an original patent is delayed…by the United States Patent & Trademark Office (“PTO”), calculating the patent term adjustment for | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
